» Articles » PMID: 10146213

Laser Treatment for Retinopathy of Prematurity

Overview
Specialty Ophthalmology
Date 1993 May 8
PMID 10146213
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Threshold retinopathy of prematurity is a level of disease at which 50% of affected infants are predicted to go blind without treatment. The Cryotherapy for Retinopathy of Prematurity Study has shown that this number can be halved with treatment. Cryotherapy, however, is stressful on the infant, leaves large scars, and is more difficult for the surgeon to administer. Laser photocoagulation with the indirect ophthalmoscope has been shown in pilot studies to be as effective as cryotherapy, less stressful on the infant, and easier for the surgeon to administer. This form of therapy may become the preferred method for treating threshold retinopathy of prematurity.

Citing Articles

Safety and Efficacy of Combination Therapy with Anti-Vascular Endothelial Growth Factor and Laser for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis.

Alamoudi A, Alnabihi A, Alsudais A, Almufarriji N, Batais W, Aldahlawi A Clin Ophthalmol. 2025; 19():1-9.

PMID: 39781265 PMC: 11706016. DOI: 10.2147/OPTH.S496737.


Comparison of Different Doses of Oral and Ocular Propranolol for Retinopathy of Prematurity: A Network Meta-Analysis.

Ortiz-Seller A, Martorell P, Rosello P, Morcillo E, Ortiz J Paediatr Drugs. 2024; 26(5):499-518.

PMID: 39112827 PMC: 11335795. DOI: 10.1007/s40272-024-00647-5.


Retinopathy of Prematurity-Targeting Hypoxic and Redox Signaling Pathways.

Zhang L, Buonfiglio F, Fiess A, Pfeiffer N, Gericke A Antioxidants (Basel). 2024; 13(2).

PMID: 38397746 PMC: 10885953. DOI: 10.3390/antiox13020148.


Retinal Hemorrhages During Examination for Retinopathy of Prematurity: A Form of Ocular Decompression Retinopathy.

Matei V, He Y J Vitreoretin Dis. 2023; 5(1):72-76.

PMID: 37009579 PMC: 9976040. DOI: 10.1177/2474126420936481.


Outcomes of near confluent laser versus combined less dense laser and bevacizumab treatment of prethreshold ROP Type 1 Zone 2: a randomized controlled trial.

Namvar E, Bolkheir A, Emadi Z, Johari M, Nowroozzadeh M BMC Ophthalmol. 2022; 22(1):454.

PMID: 36443750 PMC: 9703747. DOI: 10.1186/s12886-022-02689-0.